Posted on 6/7/16
Henry Schein Provides Seed Funding To MedShare's Disaster Relief Fund
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, recently joined MedShare . . .
Posted on 6/6/16
Why Anacor Pharmaceuticals, Inc. Stock Jumped 58.3% in May
What: Shares of Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), a biopharmaceutical company discovering, developing, and commercializing novel small-molecule therapeutics, shot up 58.3% last month, according to data from . . .
Posted on 6/6/16
Better Buy: Eli Lilly and Company vs. Pfizer
After years of sliding revenue, both Eli Lilly and Company (NYSE:LLY) and Pfizer(NYSE:PFE) are finally seeing their top lines slope upward. Longtime shareholders are pleased by . . .
Posted on 6/6/16
Why Celator Pharmaceuticals Shares Skyrocketed 100% in May
IMAGE SOURCE: CELATOR PHARMACEUTICALS.What: After reporting late-stage trial results that clear the way to an FDA approval and announcing that it has agreed to be acquired . . .
Posted on 6/5/16
ACT Oncology Is Now Precision Oncology
ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field of oncology, has changed its name to Precision Oncology (precisionforoncology.com). The new name . . .
Posted on 6/3/16
Why Keryx Biopharmaceuticals Shouldn't Be Up Today
What: Keryx Biopharmaceuticals (NASDAQ:KERX) is up 15% at 1:25 p.m. EDT after Seth Klarman's Baupost Group disclosed in a filing with the Securities and Exchange Commission . . .
Posted on 6/2/16
Q Biomed Reports On Current And New Potential Assets
Q BioMed Inc., a New York-based biotechnology acceleration company is pleased to report on new potential asset license/acquisition and an update on Man 01 development.The company . . .
New York
